Showing results (111-120 of 123) with videos related to
Sort By:
Pageof 13
Endocrinology|April 28, 1999
Androgen receptor up-regulates insulin-like growth factor binding protein-5 (IGFBP-5) expression in a human prostate cancer xenograftC W Gregory, D Kim, P Ye, et al.Cancer Research|December 29, 1998
Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genesC W Gregory, K G Hamil, D Kim, et al.The Journal of Urology|February 18, 1999
Changes in cyclin dependent kinase inhibitors p21 and p27 during the castration induced regression of the CWR22 model of prostatic adenocarcinomaR B Myers, D K Oelschlager, P N Coan, et al.Cancer Research|February 1, 1996
Acetylator genotype (NAT2)-dependent formation of aberrant crypts in congenic Syrian hamsters administered 3,2'-dimethyl-4-aminobiphenylY Feng, R J Wagner, A J Fretland, et al.The Prostate|February 11, 1999
Overexpression of cyclin D1 is rare in human prostate carcinomaL M Gumbiner, P H Gumerlock, P C Mack, et al.Gut|March 13, 2002
Aberrant P-cadherin expression is an early event in hyperplastic and dysplastic transformation in the colonR G Hardy, C Tselepis, J Hoyland, et al.Cancer Research|December 1, 1994
CWR22: androgen-dependent xenograft model derived from a primary human prostatic carcinomaM A Wainstein, F He, D Robinson, et al.Journal of Cellular Biochemistry. Supplement|January 1, 1994
The most promising surrogate endpoint biomarkers for screening candidate chemopreventive compounds for prostatic adenocarcinoma in short-term phase II clinical trialsD G Bostwick, H B Burke, T M Wheeler, et al.Cancer|August 11, 1991
Differences in the leucine aminopeptidase activity in extracts from human prostatic carcinoma and benign prostatic hyperplasiaR R Rackley, B Yang, T G Pretlow, et al.Journal of the National Cancer Institute|March 3, 1993
Xenografts of primary human prostatic carcinomaT G Pretlow, S R Wolman, M A Micale, et al.Pageof 13